Daptomycin use for gram-positive infections has increased. This cost minimization analysis aimed to determine cost and/or time savings of daptomycin over vancomycin. The estimated hospital cost savings was US$166.41 per patient, and pharmacist time saved of almost 20 minutes per patient. Daptomycin has the potential to save both time and money.
Keywords: bacterial infection; cost analyses; daptomycin; gram-positive; vancomycin.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.